To evaluate the in vivo proliferation ability of retinoblastoma cells, we examined the expression of Ki67 in four different areas from a section of five control tumors and five AICAR-treated tumors, using immunofluorescence staining. The gene discussed is MKI67; the disease is retinoblastoma.